ロード中...

OR33-5 Low Systemic Levels of Segesterone Acetate are Required to Inhibit Ovulation in Women

A one-year segesterone acetate (SA)/ethinyl estradiol (EE) contraceptive vaginal system (CVS; Annovera™) used to prevent pregnancy in women of reproductive age, was recently approved by the FDA (August 2018). Efficacy (Pearl Index of 2.98) and safety of the CVS were demonstrated in two phase 3, open...

詳細記述

保存先:
書誌詳細
出版年:J Endocr Soc
主要な著者: Archer, David, Sitruk-Ware, Regine, Mirkin, Sebastian, Brache, Vivian, Merkatz, Ruth, Kumar, Narender
フォーマット: Artigo
言語:Inglês
出版事項: Endocrine Society 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554891/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR33-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!